WALK101 unveils GMSM AI X-ray interpretation software at KIMES 2026

WALK101, led by CEO Dong Sik Chae, took part in the INSPIRE special pavilion at KIMES 2026, the 41st Korea International Medical & Hospital Equipment Show, held at COEX in Seoul from March 19 to 22. WALK101 is a medical AI startup founded in 2023 by Chae, a former orthopedic specialist at a university hospital, to tackle the inefficiencies he had experienced firsthand in clinical practice. It supplies the healthcare industry with AI software that automates the measurements physicians previously had to take by hand after an X-ray, producing them as structured data. Its training data covers every region of the musculoskeletal system and was collected in clinical practice at university hospitals, which the company says has substantially strengthened the reliability of its interpretation models. Presented at the show as WALK101's flagship solution, GMSM (General MusculoSkeletal Model) analyzes X-ray images in real time, automatically calculating biomarkers such as the angles and lengths of the musculoskeletal structures it observes, and drafts the interpretation report as well. That leaves clinicians free to focus more of their attention on consultations with patients. GMSM covers more than 20 musculoskeletal regions across the body, from the neck and shoulders to the lower back and knees, and it was trained on high-quality clinical data that university hospital specialists reviewed themselves and used in actual patient care. By assisting with image interpretation, the company says, the software lowers the risk of misdiagnosis while simplifying the administrative work required to bill for interpretation fees. Having established itself in the domestic market, WALK101 is now working through the steps needed to expand abroad. It has completed the setup of a US branch and is preparing to obtain FDA clearance, and it is pursuing an early lead in Southeast Asia through a Vietnamese branch and memorandums of understanding with nine university hospitals there. "This year's KIMES is the starting point for our full-scale push into the market," an official from WALK101 said. "With AI that eases the burden of image interpretation, we will build the infrastructure for clinicians around the world to treat patients more accurately and efficiently."